145 related articles for article (PubMed ID: 9241121)
1. CD8 T-cell response to antiretroviral therapy.
Stricker RB; Goldberg B
J Acquir Immune Defic Syndr Hum Retrovirol; 1997 Jun; 15(2):176-7. PubMed ID: 9241121
[No Abstract] [Full Text] [Related]
2. Anti-retroviral therapy in HIV-infected patients: in vitro effects of AZT and saquinavir on the response of CD4 and CD8 lymphocytes to interleukin-7.
Beq S; Bugault F; Colle JH; Lambotte O; Delfraissy JF; Thèze J
Eur Cytokine Netw; 2005 Dec; 16(4):293-9. PubMed ID: 16464744
[TBL] [Abstract][Full Text] [Related]
3. Alterations in T cell phenotype and human immunodeficiency virus type 1-specific cytotoxicity after potent antiretroviral therapy.
Seth A; Markee J; Hoering A; Sevin A; Sabath DE; Schmitz JE; Kuroda MJ; Lifton MA; Hirsch MS; Collier AC; Letvin NL; McElrath MJ
J Infect Dis; 2001 Mar; 183(5):722-9. PubMed ID: 11181148
[TBL] [Abstract][Full Text] [Related]
4. Potent antiretroviral therapy of primary human immunodeficiency virus type 1 (HIV-1) infection: partial normalization of T lymphocyte subsets and limited reduction of HIV-1 DNA despite clearance of plasma viremia.
Zaunders JJ; Cunningham PH; Kelleher AD; Kaufmann GR; Jaramillo AB; Wright R; Smith D; Grey P; Vizzard J; Carr A; Cooper DA
J Infect Dis; 1999 Aug; 180(2):320-9. PubMed ID: 10395845
[TBL] [Abstract][Full Text] [Related]
5. Frequency of class I HLA-restricted anti-HIV CD8+ T cells in individuals receiving highly active antiretroviral therapy (HAART).
Gray CM; Lawrence J; Schapiro JM; Altman JD; Winters MA; Crompton M; Loi M; Kundu SK; Davis MM; Merigan TC
J Immunol; 1999 Feb; 162(3):1780-8. PubMed ID: 9973442
[TBL] [Abstract][Full Text] [Related]
6. Effect of HIV infection and antiretroviral therapy on hepatitis B virus (HBV)-specific T cell responses in patients who have resolved HBV infection.
Lascar RM; Lopes AR; Gilson RJ; Dunn C; Johnstone R; Copas A; Reignat S; Webster G; Bertoletti A; Maini MK
J Infect Dis; 2005 Apr; 191(7):1169-79. PubMed ID: 15747254
[TBL] [Abstract][Full Text] [Related]
7. Association of T cell proliferative responses and phenotype with virus control in chronic progressive HIV-1 disease.
Malhotra U; Bosch RJ; Chan E; Wang R; Fischl MA; Collier AC; McElrath MJ
J Infect Dis; 2004 Feb; 189(3):515-9. PubMed ID: 14745710
[TBL] [Abstract][Full Text] [Related]
8. Increases in T cell telomere length in HIV infection after antiretroviral combination therapy for HIV-1 infection implicate distinct population dynamics in CD4+ and CD8+ T cells.
Kaushal S; Landay AL; Lederman MM; Connick E; Spritzler J; Kuritzkes DR; Kessler H; Levine BL; St Louis DC; June CH
Clin Immunol; 1999 Jul; 92(1):14-24. PubMed ID: 10413649
[TBL] [Abstract][Full Text] [Related]
9. Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy.
Valor L; Navarro J; Carbone J; Rodríguez-Sáinz C; Gil J; López F; Fernández-Cruz E;
Vaccine; 2008 May; 26(22):2738-45. PubMed ID: 18433946
[TBL] [Abstract][Full Text] [Related]
10. [CD8+ cell noncytotoxic antiviral response (CNAR) to HIV in nosocomial HIV-infected individuals].
Yuan L; Ma LY; Zang XH; Meng XD; Peng H; Zhao QB; Xing H; Shao YM
Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi; 2008 Jun; 22(3):195-7. PubMed ID: 19031701
[TBL] [Abstract][Full Text] [Related]
11. RANTES production by T cells and CD8-mediated inhibition of human immunodeficiency virus gene expression before initiation of potent antiretroviral therapy predict sustained suppression of viral replication.
Fransen S; Copeland KF; Smieja M; Smaill F; Rosenthal KL
J Infect Dis; 2000 Feb; 181(2):505-12. PubMed ID: 10669333
[TBL] [Abstract][Full Text] [Related]
12. Apoptosis of HIV-specific CD8+ T cells: an HIV evasion strategy.
Petrovas C; Mueller YM; Katsikis PD
Cell Death Differ; 2005 Aug; 12 Suppl 1():859-70. PubMed ID: 15818412
[No Abstract] [Full Text] [Related]
13. Immune restoration in HIV-positive, antiretroviral-naive patients after 1 year of zidovudine/lamivudine plus nelfinavir or nevirapine.
Plana M; Ferrer E; Martínez C; Podzamczer D; García F; Maleno MJ; Barceló JJ; García A; Barberá MJ; Lacarcel M; Miró JM; Gallart T; Gatell JM
Antivir Ther; 2004 Apr; 9(2):197-204. PubMed ID: 15134181
[TBL] [Abstract][Full Text] [Related]
14. Antiretroviral treatment. HIV infection in adults: better-defined first-line treatment.
Prescrire Int; 2004 Aug; 13(72):144-50. PubMed ID: 15532140
[TBL] [Abstract][Full Text] [Related]
15. Immunological effects of antiretroviral and immune therapies for HIV.
Kelleher AD; Al-Harthi L; Landay AL
AIDS; 1997; 11 Suppl A():S149-55. PubMed ID: 9451979
[No Abstract] [Full Text] [Related]
16. HIV therapeutics: points from the recent literature.
Laurence J
AIDS Read; 2003 Jul; 13(7):305, 307. PubMed ID: 12889448
[No Abstract] [Full Text] [Related]
17. Antiretroviral therapy initiation during primary HIV infection enhances both CD127 expression and the proliferative capacity of HIV-specific CD8+ T cells.
Lécuroux C; Girault I; Boutboul F; Urrutia A; Goujard C; Meyer L; Lambotte O; Chaix ML; Martinez V; Autran B; Sinet M; Venet A; ; ;
AIDS; 2009 Aug; 23(13):1649-58. PubMed ID: 19617814
[TBL] [Abstract][Full Text] [Related]
18. A mathematical model and CD4+ lymphocyte dynamics in HIV infection.
Hraba T; Dolezal J
Emerg Infect Dis; 1996; 2(4):299-305. PubMed ID: 8969246
[TBL] [Abstract][Full Text] [Related]
19. Effect of highly active antiretroviral therapy on thrombocytopenia in patients with HIV infection.
Arranz Caso JA; Sanchez Mingo C; Garcia Tena J
N Engl J Med; 1999 Oct; 341(16):1239-40. PubMed ID: 10523161
[No Abstract] [Full Text] [Related]
20. CD4+CD7-lymphocyte subset is expanded in HIV-infected patients with low CD4 cell count rescue during highly active antiretroviral therapy.
Meroni L; Varchetta S; Manganaro D; Moscatelli G; Moroni M; Galli M
AIDS; 1999 Apr; 13(5):621-2. PubMed ID: 10203388
[No Abstract] [Full Text] [Related]
[Next] [New Search]
